You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 28 No. 4, April 1973 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (57)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Serotonin and Platelet Function in Duchenne Muscular Dystrophy

Dennis L. Murphy, MD; Jerry R. Mendell, MD; W. King Engel, MD

Arch Neurol. 1973;28(4):239-242.


Abstract

Since lesions characteristic of Duchenne muscular dystrophy (DMD) are reproduced in animals by vascular ischemia from aortic ligation plus serotonin (5-HT) injections, 5-HT levels and serotonin 14C cellular transport mechanisms were studied in 14 boys with DMD. Plasma 5-HT levels were no different from those of 23 controls, but platelet 5-HT content was moderately reduced. No abnormalities were found in serotonin 14C efflux or monoamine oxidase activity. These studies suggest that a simple increase in circulating 5-HT or decrease in its enzymatic degradation is not present in DMD. The major finding was a markedly reduced initial rate of accumulation of serotonin 14C into platelets from DMD patients. This finding may be of significance to the proposed vascular pathogenesis for DMD in raising the possibility of an alteration in biogenic amine deactivation at the microvascular level.



Author Affiliations

Bethesda, Md

From the Laboratory of Clinical Science, National Institute of Mental Health, and the Medical Neurology Branch, National Institute of Neurological Diseases and Stroke, Bethesda, Md.


Footnotes

Accepted for publication Nov 24, 1972.

Read before the annual meeting of the American Academy of Neurology, St. Louis, April 28, 1972.

Reprint requests to NIH Clinical Center, 10-3S229, 9000 Rockville Pike, Bethesda, Md 20014 (Dr. Murphy).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Increased Whole Blood Serotonin Concentrations in Chronic Schizophrenic Patients
DeLisi et al.
Arch Gen Psychiatry 1981;38:647-650.
ABSTRACT  

The Muscular Dystrophies and Related Disorders: I. The Muscular Dystrophies
Furukawa and Peter
JAMA 1978;239:1537-1542.
ABSTRACT  

Catecholamine-Induced Muscle Weakness
Felmus et al.
Arch Neurol 1977;34:280-284.
ABSTRACT  

The Human Platelet: A Diagnostic and Research Tool for the Study of Biogenic Amines in Psychiatric and Neurologic Disorders
Stahl
Arch Gen Psychiatry 1977;34:509-516.
ABSTRACT  

Biochemical Abnormalities of Erythrocyte Membranes in Duchenne Dystrophy: Adenosine Triphosphatase and Adenyl Cyclase
Mawatari et al.
Arch Neurol 1976;33:489-493.
ABSTRACT  

Pathogenesis of Muscular Dystrophies
Rowland
Arch Neurol 1976;33:315-321.
ABSTRACT  

Pathogenesis of Muscular Dystrophies: Sympathetic Neurovascular Components
Appenzeller
Arch Neurol 1975;32:2-4.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1973 American Medical Association. All Rights Reserved.